SG
SGYP

Strid Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Strid Group’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-19,900
Closed -$44K – 30
2017
Q4 		$44K Buy
19,900
+7,300
+58% +$18.1K 0.02% 31
2017
Q3 		$37K Buy
+12,600
New +$43K 0.01% 31

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Strid Group's SGYP Position: Q1 2018 in Review

Strid Group sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2018, closing a stake of 19,900 shares — an estimated $44K sold.

Strid Group first reported a position in SGYP in Q3 2017 and held it in 2 quarters. The position peaked at $44K in Q4 2017. 147 funds tracked by Wall St. Rank hold SGYP as of Q1 2018.

  • Strid Group reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2018 after selling out during the quarter.
  • Strid Group sold 19,900 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2018, an estimated $44K.
  • Strid Group first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2017 and held it in 2 quarters.
  • Strid Group's Synergy Pharmaceuticals, Inc Common Stock position peaked at $44K in Q4 2017.
  • 147 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2018.

Based on Strid Group's 13F filing for Q1 2018, filed 20 Apr 2018.